rhinitis
Rhinitis refers to inflammation of the nasal mucosa and submucosal tissue. It manifests as congestion or edema, and patients often experience nasal congestion, watery runny nose, nasal itching, throat discomfort, cough and other symptoms. Various clinical rhinitis: acute rhinitis, chronic rhinitis (chronic simple rhinitis, chronic hypertrophic rhinitis, chronic dry rhinitis), allergic rhinitis (seasonal rhinitis, perennial rhinitis), dry rhinitis, atrophic rhinitis, caseous rhinitis, drug-induced rhinitis, vasomotor rhinitis, eosinophilic non-allergic rhinitis, hyperreflexic rhinitis, etc.
Related Drugs
Methylprednisolone Sodium Succinate for Injection
Indication: Unless used as a replacement for certain endocrine diseases, glucocorticoids are only a symptomatic treatment. 1. Anti-inflammatory therapy - Rheumatic diseases As a short-term adjuvant drug (to help patients get through the acute or critical period), used for: (1) post-traumatic osteoarthritis (2) synovitis caused by osteoarthritis (3) rheumatoid arthritis, including juvenile rheumatoid arthritis (individual patients may need low-dose maintenance treatment) (4) acute or subacute bursitis (5) epicondylitis (6) acute nonspecific synovitis (7) acute gouty arthritis (8) psoriatic arthritis (9) ankylosing spondylitis 2. Collagen diseases (immune complex diseases) used for the critical period or maintenance treatment of the following diseases: (1) systemic lupus erythematosus (and lupus nephritis) (2) acute rheumatic myocarditis (3) systemic dermatomyositis (polymyositis) (4) polyarteritis nodosa (5) Goodpath Good Pasture's Syndrome 3. Skin diseases (1) Pemphigus (2) Severe erythema multiforme (Stevens-Johnson syndrome) (3) Exfoliative dermatitis (4) Bullous dermatitis herpeticum (5) Severe seborrheic dermatitis (6) Severe psoriasis (7) Mycosis fungoides (8) Urticaria 4. Allergic conditions Used to control the following severe or functionally impaired allergic diseases that are difficult to treat with conventional therapy: (1) Bronchial asthma (2) Contact dermatitis (3) Atopic dermatitis (4) Serum sickness (5) Seasonal or year-round allergic rhinitis (6) Drug allergic reaction (7) Urticarial transfusion reaction (8) Acute non-infectious laryngeal edema (epinephrine is the preferred drug) 5. Eye Severe acute and chronic allergic and inflammatory conditions of the eye, such as: (1) Herpes zoster ophthalmicus (2) Iritis, iridocyclitis (3) Chorioretinitis (4) Diffuse posterior uveitis and choroiditis (5) Optic neuritis (6) Sympathetic ophthalmia 6. Gastrointestinal diseases Help patients through the critical stages of the following diseases: (1) Ulcerative colitis (systemic treatment) (2) Regional ileitis (systemic treatment) 7. Respiratory diseases (1) Pulmonary sarcoidosis (2) Beryllium poisoning (3) Combined with appropriate antituberculosis chemotherapy for fulminant or disseminated pulmonary tuberculosis (4) Loeffler's Syndrom that cannot be controlled by other methods (5) Aspiration pneumonia 8. Edema states: used for spontaneous or lupus nephritis without uremia Diuresis and relief of proteinuria in the case of leukemia syndrome 9. Immunosuppressive therapy (1) Organ transplantation for the treatment of blood diseases and tumors (2) Blood diseases: acquired (autoimmune) hemolytic anemia, spontaneous thrombocytopenic purpura in adults (only intravenous injection is allowed, intramuscular injection is contraindicated), secondary thrombocytopenia in adults, erythroblastopenia (erythrocyte anemia), congenital (erythrocyte) aplastic anemia (3) Tumors 10. For the palliative treatment of the following diseases: (1) Adult leukemia and lymphoma (2) Acute leukemia in children (3) Treatment of shock secondary to adrenal insufficiency, or shock that is unresponsive to conventional treatment due to possible adrenal insufficiency (the commonly used drug is hydrocortisone; if mineralocorticoid activity is not desired, methylprednisolone can be used). Hemorrhagic, traumatic and surgical shock that is unresponsive to conventional treatment. Although there are no complete (double-blind controlled) clinical studies, data from animal experiments show that this product may be effective for shock that is resistant to conventional treatments (e.g., fluid replacement). Please also refer to the "Infectious Shock" section in [Precautions]. 11. Others (1) Cerebral edema caused by primary or metastatic tumors, or surgery and radiotherapy in the nervous system Acute spinal cord injury in the acute critical stage of multiple sclerosis. Treatment should be started within 8 hours after the injury. - Used in combination with appropriate anti-tuberculosis chemotherapy for tuberculous meningitis with subarachnoid obstruction or tendency to obstruction - Trichinosis involving the nerves or myocardium - Prevention of nausea and vomiting caused by cancer chemotherapy (2) Endocrine disorders - Primary or secondary adrenal insufficiency - Acute adrenal insufficiency For the above diseases, hydrocortisone or cortisone is the first choice; if necessary, synthetic glucocorticoids can be used in combination with mineralocorticoids. Patients with known or suspected adrenal insufficiency. Administration prior to surgery and in the event of severe trauma or illness is not well established. - Congenital adrenal hyperplasia - Nonsuppurative thyroiditis - Hypercalcemia due to cancer
Manufacturer:
Sinopharm Ronshyn Pharmaceutical Co., Ltd.
Methylprednisolone Sodium Succinate for Injection
Indication: Unless used as a replacement for certain endocrine diseases, glucocorticoids are only a symptomatic treatment. 1. Anti-inflammatory therapy - Rheumatic diseases As a short-term adjuvant drug (to help patients get through the acute or critical period), used for: (1) post-traumatic osteoarthritis (2) synovitis caused by osteoarthritis (3) rheumatoid arthritis, including juvenile rheumatoid arthritis (individual patients may need low-dose maintenance treatment) (4) acute or subacute bursitis (5) epicondylitis (6) acute nonspecific synovitis (7) acute gouty arthritis (8) psoriatic arthritis (9) ankylosing spondylitis 2. Collagen diseases (immune complex diseases) used for the critical period or maintenance treatment of the following diseases: (1) systemic lupus erythematosus (and lupus nephritis) (2) acute rheumatic myocarditis (3) systemic dermatomyositis (polymyositis) (4) polyarteritis nodosa (5) Goodpath Good Pasture's Syndrome 3. Skin diseases (1) Pemphigus (2) Severe erythema multiforme (Stevens-Johnson syndrome) (3) Exfoliative dermatitis (4) Bullous dermatitis herpeticum (5) Severe seborrheic dermatitis (6) Severe psoriasis (7) Mycosis fungoides (8) Urticaria 4. Allergic conditions Used to control the following severe or functionally impaired allergic diseases that are difficult to treat with conventional therapy: (1) Bronchial asthma (2) Contact dermatitis (3) Atopic dermatitis (4) Serum sickness (5) Seasonal or year-round allergic rhinitis (6) Drug allergic reaction (7) Urticarial transfusion reaction (8) Acute non-infectious laryngeal edema (epinephrine is the preferred drug) 5. Eye Severe acute and chronic allergic and inflammatory conditions of the eye, such as: (1) Herpes zoster ophthalmicus (2) Iritis, iridocyclitis (3) Chorioretinitis (4) Diffuse posterior uveitis and choroiditis (5) Optic neuritis (6) Sympathetic ophthalmia 6. Gastrointestinal diseases Help patients through the critical stages of the following diseases: (1) Ulcerative colitis (systemic treatment) (2) Regional ileitis (systemic treatment) 7. Respiratory diseases (1) Pulmonary sarcoidosis (2) Beryllium poisoning (3) Combined with appropriate antituberculosis chemotherapy for fulminant or disseminated pulmonary tuberculosis (4) Loeffler's Syndrom that cannot be controlled by other methods (5) Aspiration pneumonia 8. Edema states: used for spontaneous or lupus nephritis without uremia Diuresis and relief of proteinuria in the case of leukemia syndrome 9. Immunosuppressive therapy (1) Organ transplantation for the treatment of blood diseases and tumors (2) Blood diseases: acquired (autoimmune) hemolytic anemia, spontaneous thrombocytopenic purpura in adults (only intravenous injection is allowed, intramuscular injection is contraindicated), secondary thrombocytopenia in adults, erythroblastopenia (erythrocyte anemia), congenital (erythrocyte) aplastic anemia (3) Tumors 10. For the palliative treatment of the following diseases: (1) Adult leukemia and lymphoma (2) Acute leukemia in children (3) Treatment of shock secondary to adrenal insufficiency, or shock that is unresponsive to conventional treatment due to possible adrenal insufficiency (the commonly used drug is hydrocortisone; if mineralocorticoid activity is not desired, methylprednisolone can be used). Hemorrhagic, traumatic and surgical shock that is unresponsive to conventional treatment. Although there are no complete (double-blind controlled) clinical studies, data from animal experiments show that this product may be effective for shock that is resistant to conventional treatments (e.g., fluid replacement). Please also refer to the "Infectious Shock" section in [Precautions]. 11. Others (1) Cerebral edema caused by primary or metastatic tumors, or surgery and radiotherapy in the nervous system Acute spinal cord injury in the acute critical stage of multiple sclerosis. Treatment should be started within 8 hours after the injury. - Used in combination with appropriate anti-tuberculosis chemotherapy for tuberculous meningitis with subarachnoid obstruction or tendency to obstruction - Trichinosis involving the nerves or myocardium - Prevention of nausea and vomiting caused by cancer chemotherapy (2) Endocrine disorders - Primary or secondary adrenal insufficiency - Acute adrenal insufficiency For the above diseases, hydrocortisone or cortisone is the first choice; if necessary, synthetic glucocorticoids can be used in combination with mineralocorticoids. Patients with known or suspected adrenal insufficiency. Administration prior to surgery and in the event of severe trauma or illness is not well established. - Congenital adrenal hyperplasia - Nonsuppurative thyroiditis - Hypercalcemia due to cancer
Manufacturer:
Sinopharm Ronshyn Pharmaceutical Co., Ltd.
Thymosin for injection
Indication: It is used to treat various primary or secondary T cell deficiency diseases, certain autoimmune diseases, various diseases with low cellular immune function and adjuvant treatment of tumors. Including: 1. Various types of severe hepatitis, chronic active hepatitis, chronic persistent hepatitis and liver cirrhosis; 2. Herpes zoster, genital herpes, condyloma acuminatum, etc.; 3. Prevention of upper respiratory tract infection in bronchitis, bronchial asthma, tuberculosis, etc.; 4. Premature stage of various malignant tumors and chemotherapy, combined with radiotherapy; 5. Lupus erythematosus, rheumatic and rheumatoid diseases, ankylosing spondylitis, Guillain-Barré syndrome, etc.; 6. Aplastic anemia, leukemia, thrombocytopenia, etc.; 7. Viral keratitis, viral conjunctivitis, allergic rhinitis, etc.; 8. Senile premature aging, women's menopausal syndrome, etc.; 9. Multiple furunculosis and facial skin acne, psoriasis, lichen planus, squamous cell carcinoma and epithelial keratosis, etc.; 10. Congenital immunodeficiency in children, etc.
Terfenadine Granules
Indication: 1. Seasonal allergic rhinitis, perennial allergic rhinitis. 2. Acute and chronic urticaria, etc.
Manufacturer:
Jiangsu Fubang Pharmaceutical Co., Ltd.
Fluticasone Propionate Powder
Indication: This product is used to prevent and treat seasonal allergic rhinitis (including hay fever) and perennial allergic rhinitis.
Thymosin for injection
Indication: It is used to treat various primary or secondary T cell deficiency diseases, certain autoimmune diseases, various diseases with low cellular immune function and adjuvant treatment of tumors. Including: 1. Various types of severe hepatitis, chronic active hepatitis, chronic persistent hepatitis and liver cirrhosis; 2. Herpes zoster, genital herpes, condyloma acuminatum, etc.; 3. Prevention of upper respiratory tract infection in bronchitis, bronchial asthma, tuberculosis, etc.; 4. Premature stage of various malignant tumors and chemotherapy, combined with radiotherapy; 5. Lupus erythematosus, rheumatic and rheumatoid diseases, ankylosing spondylitis, Guillain-Barré syndrome, etc.; 6. Aplastic anemia, leukemia, thrombocytopenia, etc.; 7. Viral keratitis, viral conjunctivitis, allergic rhinitis, etc.; 8. Senile premature aging, women's menopausal syndrome, etc.; 9. Multiple furunculosis and facial skin acne, psoriasis, lichen planus, squamous cell carcinoma and epithelial keratosis, etc.; 10. Congenital immunodeficiency in children, etc.
Manufacturer:
Guangzhou Invin Pharmaceutical Co., Ltd.